A close look at closure devices

Journal of Cardiovascular Surgery

Volumn 47, Issue 3, 2006, Pages 285-295

  Van Den Berg, Jos C ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Arterial closure devices; Artery; Endovascular procedures

Indexed keywords

N ACETYLGLUCOSAMINE; POLYMER; POLYSACCHARIDE;

ARTERIOVENOUS FISTULA; ARTERY OCCLUSION; BED REST; CARDIOVASCULAR EQUIPMENT; CHOLESTEROL EMBOLISM; COMPRESSION THERAPY; DIAGNOSTIC PROCEDURE; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; FALSE ANEURYSM; HEMATOMA; HEMOSTASIS; HUMAN; NERVE INJURY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RECANALIZATION; REVIEW; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ARTERIAL OCCLUSIVE DISEASES; COST-BENEFIT ANALYSIS; EMBOLIZATION, THERAPEUTIC; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMORAL ARTERY; HUMANS; LOWER EXTREMITY; PERIPHERAL VASCULAR DISEASES; POSTOPERATIVE COMPLICATIONS; SUTURES; VASCULAR SURGICAL PROCEDURES;

EID: 33745920741     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol 2003;14:865-85.
2. Tavris DR, Gallauresi BA, Lin B, Rich SE, Shaw RE, Weintraub WS et al. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol 2004;16:459-64.
3. Waksman R, King SB 3rd, Douglas JS, Shen Y, Ewing H, Mueller L et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-9.
4. Pracyk JB, Wall TC, Longabaugh JP, Tice FD, Hochrein J, Green C et al. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol 1998;81:970-6.
5. Nasser TK, Mohler ER 3rd, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol 1995;18:609-14.
6. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 2004;291:350-7.
7. Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol 2004;94:1174-7.
8. Katz SG, Abando A. The use of closure devices. Surg Clin North Am 2004;84:1267-80, vi.
9. Duda SH, Wiskirchen J, Erb M, Schott U, Khaligi K, Pereira PL et al. Suture-mediated percutaneous closure of antegrade femoral arterial access sites in patients who have received full anticoagulation therapy. Radiology 1999;210:47-52.
10. Mukhopadhyay K, Puckett MA, Roobottom CA. Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol 2005;56:409-12.
11. Schnyder G, Sawhney N, Whisenant B, Tsimikas S, Turi ZG. Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies. Catheter Cardiovasc Interv 2001;53:289-95.
12. Blanc R, Mounayer C, Piotin M, Sadik JC, Spelle L, Moret J. Hemostatic closure device after carotid puncture for stent and coil placement in an intracranial aneurysm: technical note. AJNR Am J Neuroradiol 2002;23:978-81.
13. Nicholson T, Ettles D, Robinson G. Managing inadvertent arterial catheterization during central venous access procedures. Cardiovasc Intervent Radiol 2004;27:21-5.
14. Patel SJ, Venn GE, Redwood SR. Percutaneous closure of an iatrogenic puncture of the aortic arch. Cardiovasc Intervent Radiol 2003;26:407-9.
15. Kheirabadi BS, Acheson EM, Deguzman R, Sondeen JL, Ryan KL, Delgado A et al. Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. J Trauma 2005;59:25-34.
16. Poretti F, Rosen T, Korner B, Vorwerk D. [Chitosan pads vs manual compression to control bleeding sites after transbrachial arterial catheterization in a randomized trial]. Rofo 2005;177:1260-6. German.
17. Castaneda F, Swischuk JL, Smouse HB, Brady T. Gelatin sponge closure device versus manual compression after peripheral arterial catheterization procedures. J Vasc Interv Radiol 2003;14:1517-23.
18. Gazzera C, Doriguzzi BA, Veltri A, Righi D, Barbero S, Balderi A et al. Femoral haemostosis with Vasoseal ES: experience in 150 patients. Radiol Med (Torino) 2005;109:118-24.
19. Applegate RJ, Rankin KM, Little WC, Kahl FR, Kutcher MA. Restick following initial Angioseal use. Catheter Cardiovasc Interv 2003;58:181-4.
20. Chrisman HB, Liu DM, Bui JT, Resnick SA, Sato K, Chen R et al. The safety and efficacy of a percutaneous closure device in patients undergoing uterine artery embolization. J Vasc Interv Radiol 2005;16:347-50.
21. Hong K, Liapi E, Georgiades CS, Geschwind JF. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization. J Vasc Interv Radiol 2005;16:339-45.
22. Khaghany K, Al Ali F, Spigelmoyer T, Pimentel R, Wharton K. Efficacy and safety of the perclose closers device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol 2005;26:1420-4.
23. Lasic Z, Nikolsky E, Kesanakurthy S, Dangas G. Vascular closure devices: a review of their use after invasive procedures. Am J Cardiovasc Drugs 2005;5:185-200.
24. Mlekusch W, Dick P, Haumer M, Sabeti S, Minar E, Schillinger M. Arterial puncture site management after percutaneous transluminal procedures using a hemostatic wound dressing (clo-sur p.a.d.) versus conventional manual compression: a randomized controlled trial. J Endovasc Ther 2006;13:23-31.
25. Juergens CP, Leung DY, Crozier JA, Wong AM, Robinson JT, Lo S et al. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv 2004;63:166-70.
26. Kunert M, Gremmler B, Schleiting H, Ulbricht LJ. Use of FemoStop system for arterial puncture site closure after coronary angioplasty. J Invasive Cardiol 2004;16:240-2.
27. Jaspers L, Benit E. Immediate sheath removal after PCI using a Femostop is feasible and safe. Results of a registry. Acta Cardiol 2003;58:535-7.
28. Jones T, McCutcheon H. Effectiveness of mechanical compression devices in attaining hemostasis after femoral sheath removal. Am J Crit Care 2002;11:155-62.
29. Jones T, McCutcheon H. A randomised controlled trial comparing the use of manual versus mechanical compression to obtain haemostasis following coronary angiography. Intensive Crit Care Nuts 2003;19:11-20.
30. Duffin DC, Muhlestein JB, Allisson SB, Horne BD, Fowles RE, Sorensen SG et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol 2001;13:354-62.
31. Kussmaul WG 3rd, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685-92.
32. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol 2000;85:864-9.
33. Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter Cardiovasc Interv 2001;53:174-81.
34. Tron C, Koning R, Eltchaninoff H, Douillet R, Chassaing S, Sanchez-Giron C et al. A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA. J Interv Cardiol 2003;16:217-21.
35. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinksi EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Invasive Cardiol 1999;11 Suppl B:6B-13B.
36. Ward SR, Casale P, Raymond R, Kussmaul WG 3rd, Simpfendorfer C. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol 1998;81:569-72.
37. Michalis LK, Rees MR, Patsouras D, Katsouras CS, Goudevenos J, Pappas S et al. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol 2002;25:423-9.
38. Funovics MA, Wolf F, Philipp MO, Kee S, Tichy B, Dirisamer A et al. Feasibility study of NeoMend, a percutaneous arterial closure device that uses a nonthrombogenic bioadhesive. AJR Am J Roentgenol 2003;180:533-8.
39. Macdonald S, Thomas SM, Cleveland TJ, Gaines PA. Outpatient vascular intervention: a two-year experience. Cardiovasc Intervent Radiol 2002;25:403-12.
40. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-41.
41. Exaire JE, Dauerman HL, Topol EJ, Blankenship JC, Wolski K, Raymond RE et al. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J 2004;147:31-4.
42. Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83.
43. Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol 2000;86:780-2, A9.
44. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/ IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv 2005;64:369-72.
45. Chamberlin JR, Lardi AB, McKeever LS, Wang MH, Ramadurai G, Grunenwald P et al. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv 1999;47:143-7.
46. Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: analysis of 6007 published patients. Am Heart J 1998;135:152-6.
47. Starnes BW, O'Donnell SD, Gillespie DL, Goff JM, Rosa P, Parker MV et al. Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device. J Vasc Surg 2003;38:263-71.
48. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 2004;16:243-6.
49. Wilson JS, Johnson BL, Parker JL, Back MR, Bandyk DF. Management of vascular complications following femoral artery catheterization with and without percutaneous arterial closure devices. Ann Vasc Surg 2002;16:597-600.
50. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 2004;44:1200-9.
51. Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M et al. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 2005;17:504-10.
52. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 2001;52:3-7.
53. Meyerson SL, Feldman T, Desai TR, Leef J, Schwartz LB, McKinsey JF. Angiographic access site complications in the era of arterial closure devices. Vasc Endovascular Surg 2002;36:137-44.
54. Silber S. [10 years of arterial closure devices: a critical analysis of their use after PTCA]. Z Kardiol 2000;89:383-9. German.
55. Thalhammer C, Aschwanden M, Jeanneret C, Labs KH, Jager KA. Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterisation. Vasa 2004;33:78-81.
56. Assali AR, Sdringola S, Moustapha A, Ghani M, Salloum J, Schroth G et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv 2003;58:1-5.
57. Eidt JF, Habibipour S, Saucedo JF, McKee J, Southern F, Barone GW et al. Surgical complications from hemostatic puncture closure devices. Am J Surg 1999;178:511-6.
58. Caputo RP, Ebner A, Grant W, Piemonte T. Percutaneous femoral arteriotomy repair - initial experience with a novel staple closure device. J Invasive Cardiol 2002;14:652-6.
59. Eggebrecht H, von Birgelen C, Naber C, Kroger K, Schmermund A, Wieneke H et al. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. J Invasive Cardiol 2004;16:247-50.
60. Carere RG, Webb JG, Miyagishima R, Djurdev O, Ahmed T, Dodek A. Groin complications associated with collagen plug closure of femoral arterial puncture sites in anticoagulated patients. Cathet Cardiovasc Diagn 1998;43:124-9.
61. Farouque HM, Tremmel JA, Raissi SF, Aggarwal M, Fearon WF, Ng MK et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 2005;45:363-8.
62. Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol 2000;12:395-9.
63. Gonze MD, Sternbergh WC 3rd, Salartash K, Money SR. Complications associated with percutaneous closure devices. Am J Surg 1999;178:209-11.
64. Tiesenhausen K, Tomka M, Allmayer T, Baumann A, Hessinger M, Portugaller H et al. Femoral artery infection associated with a percutaneous arterial suture device. Vasa 2004;33:83-5.
65. Whitton HH Jr, Rehring TF. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J Vasc Surg 2003;38:83-7.
66. Boston US, Panneton JM, Hofer JM, Sabater EA, Caplice N, Rowland CM et al. Infectious and ischemic complications from percutaneous closure devices used after vascular access. Ann Vasc Surg 2003;17:66-71.
67. Gemmete JJ, Dasika N, Forauer AR, Cho K, Williams DM. Successful angioplasty of a superficial femoral artery stenosis caused by a suture-mediated closure device. Cardiovasc Intervent Radiol 2003;26:410-2.
68. Kirchhof C, Schickel S, Schmidt-Lucke C, Schmidt-Lucke JA. Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa 2002;31:101-6.
69. Abando A, Hood D, Weaver F, Katz S. The use of the Angioseal device for femoral artery closure. J Vasc Surg 2004;40:287-90.
70. Corkill RA, Hughes PM, Elford JC, Roobottom CA. The in vitro and in vivo ultrasonographic appearances of the angio-seal percutaneous closure device. Clin Radiol 2002;57:930-6.
71. Ferreira AC, Eton D, de Marchena E. Late clinical presentation of femoral artery occlusion after deployment of the angio-seal closure device. J Invasive Cardiol 2002;14:689-91.
72. Katsouras CS, Michalis LK, Leontaridis I, Kolettis T, Naka KK, Goudevenos JA et al. Treatment of acute lower limb ischemia following the use of the Duett sealing device: report of three cases and review of the literature. Cardiovasc Intervent Radiol 2004;27:268-70.
73. Sprouse LR, Botta DM Jr, Hamilton IN Jr. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg 2001;33:688-93.
74. Kahn ZM, Kumar M, Hollander G, Frankel R. Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Catheter Cardiovasc Interv 2002;55:8-13.
75. Bos JJ, Hunink MG, Mali WP. Use of a collagen hemostatic closure device to achieve hemostasis after arterial puncture: a cost-effectiveness analysis. J Vasc Interv Radiol 1996;7:479-86.
76. Rickli H, Unterweger M, Sutsch G, Brunner-La Rocca HP, Sagmeister M, Ammann P et al. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv 2002;57:297-302.
77. Zhang Z, Mahoney EM, Gershony G, Ellis S, Saucedo JF, Talley JD et al. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial. Am Heart J 2001;142:982-8.